Finch Therapeutics Group, Inc.

FNCH · OTC · SIC 2836: Biological Products, (No Diagnostic Substances)
67
SEC Filings

Business Summary

PART I . Overview We are a microbiome technology company with a portfolio of intellectual property and microbiome assets. Our objectives are to realize the value of our intellectual property estate through licensing our technology to collaboration partners and enforcing our patent rights against infringing parties through intellectual property litigation and, in certain cases, to generate additional data on selected product candidates through academic collaborations. We have a robust intellectua...

Next Earnings

Q2 FY2026 — expected 2026-08-09

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2024-03-252023-12-310000950170-24-035952EDGAR60K words
2023-03-232022-12-310000950170-23-009490EDGAR
2022-03-312021-12-310000950170-22-005243EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2024-08-132024-06-300000950170-24-096246EDGAR16K words
2024-05-102024-03-310000950170-24-057912EDGAR
2023-11-082023-09-300000950170-23-060651EDGAR
2023-08-102023-06-300000950170-23-040924EDGAR
2023-05-102023-03-310000950170-23-020080EDGAR
2022-11-102022-09-300000950170-22-024152EDGAR
2022-08-112022-06-300000950170-22-016637EDGAR
2022-05-162022-03-310000950170-22-009936EDGAR
2021-11-102021-09-300000950170-21-004159EDGAR
2021-08-102021-06-300001564590-21-043094EDGAR
2021-05-132021-03-310001564590-21-027625EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2024-10-210001193125-24-240034EDGAR1K words
2024-08-120001193125-24-198362EDGAR
2024-05-240001193125-24-146454EDGAR
2024-05-170001193125-24-141816EDGAR
2024-04-030001193125-24-085435EDGAR
2024-02-230001193125-24-044511EDGAR
2023-11-170001193125-23-279821EDGAR
2023-07-070001193125-23-183823EDGAR
2023-06-280001193125-23-177539EDGAR
2023-06-230001193125-23-173133EDGAR

67 total filings indexed. 43 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001733257
TickerFNCH
ExchangeOTC
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 7753c601a6dc5f39a85c8318dd4641e5f47dcfb8172ec3da5e09c1055ecb7a70
parent: 701ab829d0af4afbc8eca7a17487aac06d9c9f9bcbf17dbcc7fde72dcd0fcf9b
content hash: fa09168a32f7c9e0a212758c8acb2e7bde4615a9e3edb02a731a00f3c9cee86a
signed: 2026-04-13T04:45:05.872Z
sources: 14 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf